Taman Jasmin Indah

334, Jln Jasmin Indah 16, 70450 Seremban, Negeri Sembilan, Malaysia

Property Transactions

2 subsales found

Price Size
Period
transactions middle 50% (P25–P75)
RM370,000
Jalan Senawang 3
1,733 sqft RM214 PSF
RM380,000
Jalan Jasmin Indah 9
1,744 sqft RM218 PSF
Legend Recent Highest Price Highest PSF

Selling in Taman Jasmin Indah? Homes here sold for a median of RM375,000.

Free to list, about two minutes, and the buyers reading this page will see it.

List your property free

Posts about Taman Jasmin Indah

What’s happening in Taman Jasmin Indah?

No posts about Taman Jasmin Indah yet. Be the first to share what’s happening here.

Market Snapshot

Residential

RM375,000

RM216 psf

Median transaction price

Loading map...

334, Jln Jasmin Indah 16, 70450 Seremban, Negeri Sembilan, Malaysia

Maps

Taman Jasmin Indah in Seremban, Negeri Sembilan recorded 2 subsale transactions between 2021 and 2026, sized between 1,725 and 1,774 sqft, with a median price of RM375K and a median price per square foot (PSF) of RM216.

This area consists exclusively of residential properties, with no commercial listings recorded.

Price remained flat, and PSF growth was PSF remained flat. The median price is RM375K, with most transactions falling within a stable range of RM370K to RM380K, and a typical market range of RM370K to RM380K.

Most transactions involved 1 - 1 1/2 storey terraced, though some variety exists in the market.

For price per square foot, the median is RM216, with most transactions between RM214 and RM218. The usual range is RM202.71 to RM228.71, showing that most units are priced quite close to each other. A typical spread (IQR) of RM26.00 and an average deviation (MAD) of RM2 indicate a highly stable PSF trend across properties.

Overall, the market in this area appears stable with consistent appreciation, making it an attractive option for both investors and homebuyers. The consistent property type and stable pricing make it easier to assess value and compare trends. Limited transaction history suggests carefully evaluating comparable sales data.